Updates from Dr. Rob Swanda!
drswanda.com
28 August 2022
Recent content from Dr. Rob!
Bivalent mRNA vaccine boosters targeting mutated SARS-CoV-2 variants are almost here! The US government has secured supply of more than 170m doses and FDA approval is anticipated to be coming within the next 1-2 weeks.
In his latest video, Rob breaks down how bivalent boosters work. Watch below!
Monkeypox: Where did it originate? How did we get where we are today? Are there any treatments? How does it compare to other infectious diseases like COVID-19, Smallpox or Polio?
Rob has it all covered in the latest blog post "Monkeypox: The Past, Present and Foreseeable Future".
The article is available to read in English, Spanish, German and French!
Science News This Week
A new Dengue Fever vaccine is in development! US-based company Codagenix announced an US $4.4m award from Department of Defense to progress their dengue vaccine candidate through clinical trials. The vaccine is multivalent in that it targets all 4 strains of dengue virus - thought to be the first of it's kind.
Read more!
___
The White House Office of Science and Technology Policy (OSTP) announced that federally-funded / taxpayer supported research will be now be open access, meaning the information will be free to the public.
Have your at-home COVID-19 test kits expired? Don't throw them out just yet! The FDA has been working with manufacturers to continue testing the kits for 12 and even 18 months. Extended shelf-life dates are published on the FDA's website where you can search and see if your brand of test is good to keep using.
Did you know?
There are 4 types of lipids used in COVID-19 mRNA vaccines?
They are: ionizable lipids which help bind to the mRNA, PEGylated lipids which help stabilize the particle and phospholipid & cholesterol molecules which give the particles structure.
Be on the lookout for...
Dr. Rob continues his Carbon Health 'meet the experts' series bringing physicians to you! Dr. Rob and Dr. Aaron Weinberg will shortly release the next in the series - a Q&A on all things bivalent vaccines.
